Botfet / Company detail

UTHR

universe

United Therapeutics Corporation

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic16.1%

Gross Margin87.9%

Revenue Cagr17.2%

Fcf Conversion78.0%

Fcf Yield4.1%

Interest Coverage93.3x

Market Cap B$25.3B

Pe19.4

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener